Jaime Segrist

Papers

Total Citations

H-Index

About

Jaime Segrist is a surgical oncologist whose research focuses on refining minimally invasive staging techniques for gynecologic cancers, particularly ovarian and endometrial malignancies. Her most cited work, a 2020 study comparing extraperitoneal versus transperitoneal laparoscopic aortic staging, has garnered 16 citations and directly addresses a critical clinical question: how to reduce surgical complications while maintaining diagnostic accuracy. By systematically evaluating these two approaches, Segrist has contributed to evidence-based guidelines that help surgeons choose the safest route for retroperitoneal lymph node dissection, a procedure essential for determining cancer stage and guiding adjuvant therapy. Her research underscores a commitment to improving patient outcomes through meticulous surgical technique and comparative effectiveness studies. While her citation count reflects a focused, early-career impact, her work is already influencing practice patterns in gynecologic oncology. Segrist’s contributions are particularly valuable for trainees and surgeons seeking to balance the oncologic necessity of comprehensive staging with the imperative to minimize morbidity, making her a rising voice in the field of minimally invasive gynecologic surgery.